Slingshot Biosciences Appoints Tiffany Salas-Morris as Chief Commercial Officer
Slice of Healthcare Team
Nov 08, 2024
Key Highlights
- Tiffany Salas-Morris appointed as Chief Commercial Officer (CCO)
- Over two decades of expertise in life sciences and biotech
- Will drive commercial strategy to expand market presence and customer engagement
- Focus on scaling cell mimic technology to support advanced therapies
Source: Business Wire
Notable Quotes
“ We are thrilled to welcome Tiffany Salas-Morris to the Slingshot Biosciences team. Tiffany's deep industry knowledge and proven track record in driving commercial success make her the ideal leader to help us scale our business and bring our innovative cell mimic technology to a broader market. ”
Dr. Jeffrey Kim, Founder, CEO, and President at Slingshot Biosciences
“ I am honored to join Slingshot Biosciences at such an exciting time in the company's growth. The innovative work being done here has the potential to revolutionize current methodologies, and I am eager to contribute to our mission of helping scientists develop advanced therapies and reliable tests that improve patient outcomes. ”
Tiffany Salas-Morris, Chief Commercial Officer at Slingshot Biosciences
